scholarly article | Q13442814 |
P2093 | author name string | Nakao K | |
Ito Y | |||
Monden M | |||
Nakahara M | |||
Sakon M | |||
Matsuura N | |||
Tsujimoto M | |||
Takeda T | |||
Nagano H | |||
Nakamori S | |||
Umeshita K | |||
Dono K | |||
P2860 | cites work | Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics | Q24564912 |
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation | Q24642901 | ||
Cell death: the significance of apoptosis | Q29617620 | ||
The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis | Q29618601 | ||
Prognostic significance of Ki-67, p53, and Bcl-2 expression in prostate cancer patients with lymph node metastases: a retrospective immunohistochemical analysis | Q38472075 | ||
Apoptosis in human hepatocellular carcinoma and in liver cell dysplasia is correlated with p53 protein immunoreactivity | Q39568347 | ||
Expression of proliferation associated antigens and detection of numerical chromosome aberrations in primary human liver tumours: relevance to tumour characteristics and prognosis | Q39585393 | ||
Hepatocellular carcinomas with a high proliferation index and a low degree of apoptosis and necrosis are associated with a shortened survival | Q39992659 | ||
Prognostic biomarker study in pathologically staged N1 non-small cell lung cancer | Q44071087 | ||
Apoptosis as a prognostic factor in colorectal carcinoma | Q45126395 | ||
Ki-67 expression in relation to clinicopathological variables and prognosis in colorectal adenocarcinomas. | Q50927416 | ||
Apoptosis in bladder cancer as related to standard prognostic factors and prognosis. | Q52881706 | ||
The cell cycle associated change of the Ki-67 reactive nuclear antigen expression | Q70370564 | ||
Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays | Q70646233 | ||
Association between the apoptotic index and established prognostic parameters in endometrial adenocarcinoma | Q70936632 | ||
Cytometric measurement of cell proliferation in echo-guided biopsies from focal lesions of the liver | Q71134000 | ||
Apoptosis and proliferation of human hepatocellular carcinoma | Q71347409 | ||
Ki-67 antigen expression in hepatocellular carcinoma using monoclonal antibody MIB1. A comparison with proliferating cell nuclear antigen | Q71710650 | ||
Apoptosis in renal cell carcinoma: detection by in situ end-labeling of fragmented DNA and correlation with other prognostic factors | Q71727720 | ||
Evaluation of Ki-67 expression as a prognostic feature in hepatocellular carcinoma in cirrhosis | Q71784112 | ||
Enhanced apoptosis predicts shortened survival in non-small cell lung carcinoma | Q71805228 | ||
A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA | Q72066939 | ||
The extent of apoptosis in different types of high grade prostatic carcinoma | Q72410009 | ||
Histological grade, perineural infiltration, tumour-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma | Q72606732 | ||
In situ end-labelling detects DNA strand breaks in apoptosis and other physiological and pathological states | Q72818153 | ||
Ki-67 immunostaining in 322 primary breast cancers: associations with clinical and pathological variables and prognosis | Q73684229 | ||
Apoptotic index in ovarian carcinoma: correlation with clinicopathologic factors and prognosis | Q73702630 | ||
Ki-67, ploidy and S-phase fraction as prognostic factors in gastric cancer | Q73785755 | ||
Fas antigen expression in hepatocellular carcinoma tissues | Q74151675 | ||
The impact of tumour angiogenesis, p53 overexpression and proliferative activity (MIB-1) on survival in squamous cervical carcinoma | Q74202044 | ||
Prognosis in malignant mesothelioma related to MIB 1 proliferation index and histological subtype | Q74297872 | ||
Ki-67 expression as a prognostic marker in patients with hepatocellular carcinoma | Q74505617 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 747-751 | |
P577 | publication date | 1999-10-01 | |
P1433 | published in | British Journal of Cancer | Q326309 |
P1476 | title | Both cell proliferation and apoptosis significantly predict shortened disease-free survival in hepatocellular carcinoma | |
P478 | volume | 81 |
Q80531065 | A new way to look at liver cancer |
Q34747158 | Assessment of the Proliferative Marker Ki-67 and p53 Protein Expression in HBV- and HCV-related Hepatocellular Carcinoma Cases in Egypt. |
Q39289574 | Breast cancer metastasis suppressor 1 regulates hepatocellular carcinoma cell apoptosis via suppressing osteopontin expression |
Q73877869 | Caspase-3 activity as a prognostic factor in colorectal carcinoma |
Q74234032 | Cell proliferation and apoptosis with BCL-2 expression in renal cell carcinoma |
Q37297819 | Clinicopathologic Correlations of E-cadherin and Prrx-1 Expression Loss in Hepatocellular Carcinoma |
Q26784351 | Clinicopathological and prognostic significance of high Ki-67 labeling index in hepatocellular carcinoma patients: a meta-analysis |
Q35010945 | Construction and clinical significance of a predictive system for prognosis of hepatocellular carcinoma |
Q73651365 | EBAG9/RCAS1 expression in hepatocellular carcinoma: correlation with tumour dedifferentiation and proliferation |
Q73836285 | Evaluation of cell proliferation, apoptosis, and angiogenesis in transitional cell carcinoma of the renal pelvis and ureter |
Q52356831 | Exploitation of Apoptotic Regulation in Cancer. |
Q36622264 | Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma |
Q44716307 | Expression of 8-hydroxy-2'-deoxyguanosine in chronic liver disease and hepatocellular carcinoma |
Q42996334 | Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma |
Q36638176 | Hepatic progenitor cells in human liver tumor development |
Q78622520 | Hepatocellular carcinoma with an unusual medullary-like histology and signs of regression ("medullary-like hepatocellular carcinoma") |
Q34207073 | Hepatocellular carcinomas in native livers from patients treated with orthotopic liver transplantation: biologic and therapeutic implications |
Q44563223 | Hormone receptors in non-malignant meningiomas correlate with apoptosis, cell proliferation and recurrence-free survival |
Q39590514 | IGFBP7 downregulation is associated with tumor progression and clinical outcome in hepatocellular carcinoma |
Q42445767 | Induction of apoptosis in mouse liver adenoma and carcinoma in vivo by transforming growth factor-beta1. |
Q26853543 | Management of hepatocellular carcinoma: Predictive value of immunohistochemical markers for postoperative survival |
Q44197102 | Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma |
Q34668320 | The prognostic molecular markers in hepatocellular carcinoma |
Q57757149 | p27Kip1 is an independent predictor of recurrence after surgical resection in patients with small hepatocellular carcinoma |